Shares of Applied Graphene Materials ticker lookup code: LON:AGM has gained 15% or 1.43 points in today’s trading session so far. Traders have remained positive throughout the trading session. The ...

Detailed results from the Phase III ADAURA trial showed AstraZeneca PLC (LON:AZN) Tagrisso demonstrated a statistically significant and clinically meaningful improvement in disease-free survival in the adjuvant treatment of patients with early-stage ...

AstraZeneca PLC (LON:AZN) and Daiichi Sankyo Company Limited’s Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation in the US for the treatment of patients with gastric cancer, including gastroesophageal junction ...

Stock in Associated British Foods with EPIC code: LON:ABF has gained 1.15% or 19 points throughout today’s trading session so far. Investors have remained positive while the stock has been ...

AstraZeneca PLC (LON:AZN) is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make the University of Oxford’s ...

AstraZeneca PLC (LON:AZN) and MSD Inc., Kenilworth, N.J., US today announced that Lynparza has been approved in the US for patients with homologous recombination repair gene-mutated metastatic castration-resistant prostate cancer. The approval ...

Astrazeneca PLC with ticker code (AZN) now have 4 analysts in total covering the stock. The consensus rating is ‘Strong_Buy’. The range between the high target price and low target ...

AstraZeneca PLC (LON:AZN) Bevespi Aeroshere (glycopyronium/formoteral fumarate) has been approved in China as a maintenance treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis ...

Astrazeneca PLC with ticker code (AZN) now have 4 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The range between the high target price and ...

AstraZeneca plc using EPIC/TICKER code (LON:AZN) has had its stock rating noted as ‘Retains’ with the recommendation being set at ‘BUY’ this morning by analysts at Bryan Garnier. AstraZeneca plc ...